Pharmacogenetic Aspects of Type 2 Diabetes Treatment

Pharmacogenetic Aspects of Type 2 Diabetes Treatment

In this article, we analyze the role of different variants of the KCNJ11, TCF7L2, SLC22A1, SLC22A3, CYP2C9, CYP2C8, PPARγ genes polymorphisms in efficacy of diabetes mellitus pharmacotherapy. T allele of the KCNJ11 rs2285676 gene polymorphism and G allele of KCNJ11 rs5218 gene polymorphism are assoc...

Full description

Bibliographic Details
Main Authors: N. O. Pozdnyakov, I. N. Kagarmanyan, A. E. Miroshnikov, E. S. Emelyanov, A. A. Gruzdeva, A. M. Sirotkina, I. A. Dukhanina, A. A. Milkina, A. A. Khokhlov, S. O. Pozdnyakov
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2020-07-01
Series:Acta Biomedica Scientifica
Subjects:
diabetes mellitus
pharmacogenetics
kcnj11
tcf7l2
slc22a1
slc22a3
cyp2c9
cyp2c8
pparγ
Online Access:https://www.actabiomedica.ru/jour/article/view/2362

Internet

https://www.actabiomedica.ru/jour/article/view/2362

Similar Items